video-tag-article">
NEW YORK (dpa-AFX) – The start of the stock market week for the central banks and the numbers of large US technology giants could fail on Monday. Investors are initially hesitant about major events, particularly in the technology sector. This reacts particularly sensitively to rising interest rates. The US Federal Reserve’s outlook on further interest rate developments will therefore be particularly important on Wednesday.
The highly tech-heavy Nasdaq 100 index was appraised a good one percent lower to 12,032 points by broker IG an hour before the start. So far this year, however, he has had a particularly good run with an increase of more than eleven percent. Wall Street’s leading index, the Dow Jones Industrial
, is seen less strongly on Monday with 33,771 points, down half a percent. So far this year, however, it has only increased by 2.5 percent.
In the course of the week, the course on the stock exchanges should be reset with the expected interest rate decisions. The US Federal Reserve will be the first to decide on its key interest rate on Wednesday, followed by the European Central Bank (ECB) and the Bank of England (BoE) on Thursday. The Fed is expected to hike interest rates by another 0.25 percentage point, further slowing the pace of rate hikes.
In addition, the results of the US corporations Meta ,
Amazon Alphabet and Apple
attached much importance from the middle of the week. The prices of these tech industry giants fell between 0.5 and 1.4 percent before the market on Monday. Pierre Veyret from broker ActivTrades justified this with profit-taking. In Asia and Europe, a course correction in tech stocks had already taken place on Monday.
The recently listed medical technology group GE Healthcare
meanwhile ended the past year with a decline in profits. Higher inflation-related costs and investments in research and development, such as the competitor from Siemens Healthineers, had a negative impact and Phillips
announced on Monday in Chicago (US state of Illinois).
On Tuesday then with UPS Pfizer
McDonald’s Caterpillar
General Motors oder ExxonMobil
top-class quarterly reports from other industrial sectors are again expected.
Curevac is worth a look for news , the title of the Tübingen vaccine researcher listed in the USA rose by 5.7 percent before the market. The shares are thus further stabilizing after their fluctuations, which had recently triggered encouraging early-stage study data on new Covid and flu vaccines. Curevac has now provided similar data again, which concern older adults for both indications./tih/mis
ISIN US2605661048 US6311011026 US78378X1072
AXC0205 2023-01-30/14:52
Copyright dpa-AFX business news GmbH. All rights reserved. Redistribution, republication or permanent storage without the express prior consent of dpa-AFX is not permitted.
